BioSpace News Archive

Business

Grants awarded to oral and maxillofacial surgeons for volunteer service

The American Association of Oral and Maxillofacial Surgeons and the Henry Schein Cares Foundation are supporting the volunteer service of four oral and maxillofacial surgeons through the joint Global Outreach Program.

December 18, 2019
·
2 min read
Drug Development

MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b

MODAG announced the clinical trial initiation of, and recruitment for, a first-in-human Phase 1 study of lead candidate, anle138b in healthy volunteers.

December 18, 2019
·
5 min read
Drug Development

Data Monitoring Committee Completes Final Scheduled Review of Mesoblast’s Phase 3 Trial of Revascor in Advanced Chronic Heart Failure

Mesoblast Limited announced that the independent Data Monitoring Committee overseeing the Phase 3 trial of Revascor for advanced chronic heart failure has held its tenth and final scheduled meeting, and has recommended that the trial continue as planned.

December 18, 2019
·
3 min read
Deals

Conventus Orthopaedics Acquires Novel Intramedullary Technology from IntraFuse

Conventus Orthopaedics, Inc., a medical device company dedicated to revolutionizing fracture treatment, today announced that it has acquired all assets of IntraFuse, LLC. IntraFuse has developed proprietary intramedullary implants for the minimally invasive repair of fractures, including fibula fractures.

December 18, 2019
·
2 min read
Business

Axogen awarded research grant from the Advanced Regenerative Manufacturing Institute

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced it has been awarded a grant to research and develop an automated bioprocessing system for human tissue scaffolds.

December 18, 2019
·
3 min read
Deals

KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital

Principal and Interest Payments on Outstanding Debt in Principal Amount of $77.7M Pushed to March 31, 2021; Expected to Extend Cash Runway to New Maturity Date

December 18, 2019
·
9 min read
Business

BridgeBio Pharma’s Origin Biosciences Enters Partnership With Medison to Commercialize BBP-870 in Israel for MoCD Type A

BridgeBio Pharma, Inc. and Medison Pharma Ltd. have entered into an exclusive license agreement under which Medison received rights from Origin to distribute, market, sell and otherwise commercialize Origin’s drug product known as fosdenopterin in Israel..

December 18, 2019
·
7 min read
Policy

U.S. FDA Acknowledges Receipt of Evofem Biosciences’ New Drug Application Resubmission for Amphora® for the Prevention of Pregnancy

Evofem Biosciences, Inc., a clinical-stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration acknowledged receipt of the New Drug Application resubmission for Amphora®, a Multipurpose Vaginal pH Regulator, for the prevention of pregnancy.

December 18, 2019
·
5 min read
Deals

Danaher Announces Final Results Of Envista Exchange Offer

Danaher Corporation announced the final results of its previously announced offer to holders of shares of Danaher common stock to exchange their shares of Danaher common stock for shares of common stock of Envista Holdings Corporation owned by Danaher.

December 18, 2019
·
5 min read
Business

Jeffrey Goldberg Appointed Chief Executive Officer and Director of Immunitas Therapeutics

Immunitas Therapeutics (“Immunitas”), an innovative single cell genomics discovery platform company focused on developing breakthrough immuno-oncology therapies, today announced it has appointed Jeffrey M. Goldberg as Chief Executive Officer and Director.

December 18, 2019
·
4 min read